Representing the highest level of evidence and quality assessment for healthcare interventions, Randomised Controlled Trials (RCTs) are the ‘gold standard’ of medical research. The power of this evidence, however, is only as strong as its measure. The effects of poor medication adherence are well documented in both the trial and real-world setting, contributing to treatment …
HealthBeacon explores sustainable alternatives to sharps waste disposal and the impact of our HealthBeacon Green Labs initiative This year, HealthBeacon commissioned GlobalPSC, an independent, not-for-profit organisation dedicated to facilitating the development of effective product stewardship and EPR schemes globally, to build upon and update research that they had previously published on the use of Reusable …
Medication Event Monitoring Systems Provide Improved Measures of Adherence: How HealthBeacon’s Injection Care Management System™ can Enhance Confidence in Adherence Rates. September 2020.By Dr.Sharifah Sarhan, MB, BCh, BAO, Medical Science Liaison Officer & Sean Glynn, MSc, Director of HEOR The ability to provide patients and their healthcare practitioners with individualised and real-time medication adherence data …
Virtual Injection Training study represents new approach to successful patient onboarding. September 2020. Here at HealthBeacon we are continuously looking for novel approaches to successful onboarding of patients into our Injection Care Management System (ICMS™). Research into video assisted injection training for patients by Sean Glynn, Director of Health Economics and Outcomes Research, explores this …
HealthBeacon appoints new Medical Science Liaison. August 2020. HealthBeacon is happy to announce the latest addition to our expanding team, Dr. Sharifah Sarhan, as our new Medical Science Liaison. Having experience across several medical specialities as a junior doctor, Sharifah joins HealthBeacon in our Dublin Headquarters to facilitate research, assist in regulatory affairs and to …
Medics Need Apply: The Increasing Role of Doctors outside the Clinical World Read More »
COVID-19 Response Jim Joyce CEO and Co-Founder, HealthBeacon HealthBeacon appreciates and understands that our healthcare systems and healthcare workers feel the weight of the world on their shoulders. At this time, HealthBeacon is working with governments and insurers to immediately add new capabilities within our Injection Care Management System. Please take a moment to listen to HealthBeacon CEO Jim …
Q&A with Lara Kelly, Head of Data Analytics, HealthBeacon In January, we launched our adoption series, assessing the multiple considerations required to create useful technologies within the complex landscape of healthcare. This was followed by HealthBeacon CEO, Jim Joyce, reflecting on the importance of keeping technology human, making reference to the significance of simple acts, such as the inclusion of a smile. Next, Dr. Zara Kinsella Fullerton does a Q&A session with Lara Kelly, head of Data …
By Jim Joyce, CEO & Co-Founder of HealthBeacon and Dr. Zara Fullerton Kinsella, Medical Science Liaison for HealthBeacon This is the second series reflecting on the adoption of healthcare technologies. In this piece, Jim Joyce asks the question – “Should Digital Health Tools Smile?” “I gave them a smile, they gave me one back, so I …
Achieving Patient Adoption: Should Digital Health Tools Smile? Read More »
By Katie Roche and Dr. Zara Fullerton Kinsella, Medical Science Liaison for HealthBeacon | Illustrations by Luke Higashikawa Companies feed our endless appetite for healthcare technologies, but are patients really using them? Read Katie Roche and Dr. Zara Fullerton Kinsella’s thoughts, the first of four articles reflecting on the adoption of healthcare technologies. In this piece, they explore …
Adoption of Healthcare Technology: A Unique Dilemma Read More »
Sean Glynn, M.S., is the Director of HEOR and Strategic Initiatives for HealthBeacon in North America Zara Fullerton Kinsella, Medical Doctor, is the Medical Science Liaison for HealthBeacon A physician recently described an interaction where a patient was ending a course of therapy due to a poor response to treatment. The patient asked, “What should I …
The Impact of Connected Devices on Medication Adherence Read More »
